MRNA

Power Core

Moderna's moat is its end-to-end ownership of the mRNA technology stack, from sequence design through lipid nanoparticle delivery to manufacturing, which enables parallel development across dozens of therapeutic programs at a speed and cost structure no traditional pharmaceutical company can replicate internally.